MedPath

Oedematous Lower Limb Subcutaneous Drainage in Palliative Care

Not Applicable
Terminated
Conditions
Edema
Interventions
Other: subcutaneous drainage
Registration Number
NCT02473744
Lead Sponsor
University Hospital, Limoges
Brief Summary

* Background : Edema of lower extremities is a concern ranging from 19 % to 60% of palliative cancer patients. Lymphedema decreases mobility, induces pain, impacts daily activities, esthetic and behavior. Usual treatment is based on diuretics and physiotherapy but is often unsuccessful. In case of conventional treatment failure, in palliative care, subcutaneous drainage can be discussed with the patients. The technique is simple, easy to use but remains off the record. Since 2004, 23 cases were reported with various methods. All the cases reported were undertaken with various technical approaches and efficacy criteria.

* Purpose : Investigator hypothesize that the subcutaneous drainage of edema (SDO) is effective in case of refractory lymphedema of the lower limbs in palliative care and leads to an improvement in QOL in terms of behavioral and autonomy.

Detailed Description

• Abstract : In palliative care, lymphedema results from various associations of cancer, hypoalbuminemia, electrolytic disturbances or organ failure. The lymphatic circulation cannot be summarized by the Starling's equation and obstruction cannot explain everything. An interstitial hypothesis underlines the role of the lymphatic pump and edema volume can be a crucial point. The SDO, via the direct liquid removal, can restore the lymphatic pump function. This volumetric effect can explain the long time effect of the SDO and the large range of liquid amount reported in effective SDO. The superficial lymphatic system, in the superficial layer of derma, drains 80 % of lymph flow. In edema, the increased volume leads to the creation of subcutaneous interconnected lacunas. The subcutaneous site for drainage is justified.

After topic anesthesia, three subcutaneous channels are created on the ankle's medial face of the edematous limbs and liquids are absorbed by pads. An additional drainage can be done on the external face of the thigh with liquid collecting bags in bedridden patients.

The study includes clinical examination, total and segmental bioelectrical impedance measured at J0, J4 and on exit or at J7 at the latest and daily weight, umbilic abdominal perimeters and segmental circumferences and QOL evaluation before and after SDO. Bioelectrical impedance is collected from hand-foot, thigh root-foot and under patella calf - foot electrodes. Segmental circumferences are collected at thigh, calf and ankle points identified from bone relief distance.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Age ≥ 18
  • palliative care patients
  • Karnofsky Scale < 50%
  • Uni or bilateral lower limb oedema even if associated with lumbar or pelvi-scrotal oedema or ascitis whatever etiology involved (cancer, organ failure, hypoalbuminemia...)
  • Effective Social security regimen affiliation
  • Signed informed consent
Exclusion Criteria
  • Refusal to take part in the study
  • Local anesthesic contraindication
  • Infected skin lesions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Oedematous lower limb subcutaneous drainagesubcutaneous drainageIn case of lymphoedema in palliative situation, a subcutaneous drainage can be performed. It is a simple method, easy to use. After topic analgesia, three subcutaneous channels are created and an absorbent pad collects the lymphatic fluid.
Primary Outcome Measures
NameTimeMethod
Karnofsky's scale7 days

Change in autonomy evaluated by Karnofsky's scale between Day 7 and Day 0

Secondary Outcome Measures
NameTimeMethod
Karnofsky's scale4 Days

Change in autonomy evaluated by Karnofsky's scale between Day 4 and Day 0

The 15th item of the European Organisation for Research and Treatment of Cancer quality of life questionnaires of palliative cancer care patients (EORTC QLQ C15 PAL),4 days and 7 days

Changes in quality of life evaluated by the 15th item of the EORTC QLQ C15 PAL scale between between Day 4/Day 7 and Day 0

Modify Dermatology Life Quality Index (MDLQI)4 days and 7 days

Changes in quality of life related to lymphedema evaluated by the MDLQI between Day 4/Day 7 and Day 0

Verbal numeric scale for pain4 days and 7 days

Changes in pain evaluated by the verbal numeric scale between Day 4/Day 7 and Day 0

Bioelectrical impedance analysis of lower limbs, calves and thighs4 days and 7 days

Changes in bioelectrical impedance of lower limbs, calves and thighs between Day 4/Day 7 and Day 0.

Segmental limb circumferences measurement4 days and 7 days

Variation of the physical measures in time. Changes in segmental limb circumferences between Day 4/Day 7 and Day 0

Abdominal perimeter measurement4 days and 7 days

Variation of the physical measures in time. Changes in abdominal perimeter between Day 4/Day 7 and Day 0

Weight measurement4 days and 7 days

Variation of the physical measures in time. Changes in weight between Day 4/Day 7 and Day 0

Trial Locations

Locations (3)

Hospital

🇫🇷

Valenciennes, France

Joseph Ducuing hospital

🇫🇷

Toulouse, France

University hospital

🇫🇷

Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath